Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Integral Diagnostics Ltd. ( (AU:IDX) ) is now available.
Integral Diagnostics Ltd. has announced the issuance of 71,911 performance rights under an employee incentive scheme. These securities are unquoted and subject to transfer restrictions, reflecting the company’s commitment to incentivizing its workforce and aligning employee interests with corporate performance.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$3.20 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. operates in the healthcare industry, specializing in diagnostic imaging services. The company focuses on providing high-quality radiology services across Australia and New Zealand, catering to a wide range of medical imaging needs.
Average Trading Volume: 971,359
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$913.7M
Find detailed analytics on IDX stock on TipRanks’ Stock Analysis page.